China NT Pharma Group Company Limited, together with its subsidiaries, engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China. It manufactures, sells, and trades in prescription medicines; offers products in the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.028100303970868067 | N/A |
Market Cap | $74.21M | N/A |
Shares Outstanding | 2.64B | N/A |
Employees | 124.00 | N/A |